January to March 2007

TTP LABTECH EXTENDS GLOBAL REACH Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia New Zealand

Dymension 2D Gel Analysis Software installed at Specialist University

Biacore to host DiPIA 2007 conference in Phoenix, Arizona May 6-9, Pointe Hilton Squaw Peak Resort

More Rapid Than Expected Type 2 Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016

Affimed Closes € 25 million (US $ 32 million) Series B financing

Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US

BPI Announces First Sales of Next-Generation TISSUEscope ™

BAC AND GE HEALTHCARE ANNOUNCE FVIII PURIFICATION MEDIA COLLABORATION

Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon®, its long-lasting, Interferon-alpha drug

Bt maize crops delivering health, wealth and environmental benefits in Europe

CAMBRIDGE ANTIBODY TECHNOLOGY NAMES ITS NEW BUILDING IN HONOUR OF PROFESSOR SIR AARON KLUG

Roche gains DNA technology in CuraGen unit takeover

Migraine market: Trexima approval delays benefits generic triptan

Hollis-Eden requests approval of metabolic drug trial

Carrington Laboratories to manufacture sublingual vaccines

Avanir plans restructuring, ends collaborations

Rise of the superbug set to drive antibacterials growth

Clinical Data and Roche Sign Co-Marketing Agreement Relating to Cogenics Division Acquisition of 454 GS FLX Sequencing System

Nitec Pharma AG closes CHF 32 million (approx. US$ 26 million) Series B financing led by NGN Capital

Cellexus Biosystems appoints Dr Julie Bick as its US-based Chief Scientific Officer

As Global Fungal Infections Soar, Market for Antifungals Heads for $7 Billion

Healthy Global Market for Contrasting Agents Growing to $15 Billion by 2010

$9.8 Billion World Implantable/Injectable Drug Delivery Market Set for Healthy Growth

OXFORD BIOMEDICA AND SANOFI-AVENTIS ENTER GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALISE TROVAX FOR CANCER

ProFibrix raises up to $ 11 million (€ 8.5 million) Series A financing led by Index Ventures

HRA Pharma commences UK-based Phase III trial of Ella®, a second-generation emergency contraceptive

deltaDOT strengthens commercial team with appointment of Vice President, Sales

Worldwide Lateral Flow Point-of-Care Tests Market to Surpass $2.7 Billion by 2010

Global Molecular Diagnostics Market...Skyrocketing to $92 Billion by 2016?

World Vaccine Market Offers Promise of Growth Exceeding $15 Billion in 2012!

Arrowhead Conferences’ Drug Delivery 2007 to Take Place April 9th-11th 2007 in San Francisco

Haptogen’s strategy rewarded

MorphoSys's AbD Serotec Expands Antibody License Agreement with Medical Research Council

Syrris announce new West Coast office to meet growing customer demand

Top UK University is First to Install Dyversity 2D Gel Imager

9th INTERNATIONAL CONFERENCE ON BIOLOGY AND SYNCHROTRON RADIATION

SOLVO Biotechnology is introducing the revolutionary BCRP HAM membranes and vesicles!

Dutch AM-Pharma announces positive results of Phase IIa trial in Acute Renal Failure

Australian biotech Virax grants French Transgene technology license for immunotherapeutic product

GSK hay fever drug relieves symptoms

The FDA has approved Cymbalta to treat generalized anxiety disorder (GAD).

Abbott cleared to market Crohn's drug in US

An expert panel has recommended Sanofi-Aventis' avian flu vaccine to the FDA

Pfizer says HIV drug suppresses virus

Alzheimer's disease: physicians do not always practice what NICE preaches

Double-Digit-Growing Cancer Therapeutics Market Could Top $89 Billion by 2011!

OXFORD BIOMEDICA TO ACQUIRE OXXON THERAPEUTICS

Deep in vivo Imaging With New Multiphoton Excitation (MPE) Microscope range from Olympus

Olympus introduces the new 5-megapixel DP25 digital colour camera for microscopes

Thermo Fisher Scientific Introduces High Precision Bottle-top Dispenser Range.

Thermo Fisher Scientific Introduces the World's First Electronic Pipette with a Six Language Interface

Global impact of biotech crops: socio-economic and environmental effects in the first ten years of commercial use

InforSense® Customer Hub Unveiled to Empower Life Scientists and Informaticians

Biotechnology industry welcomes calls by EU leaders to act now to deliver sustainable, secure and competitive biofuels

BioAlliance Pharma Sets Up European Joint Venture with Spepharm to Sell Loramyc(R)

ACRUX AND ORGANON FURTHER EXPAND THEIR COLLABORATION

Protagen AG announces the launch of Modiro - The PTM-Explorer

Cobra joins international consortium to develop oral vaccines

MedicWave launches Proteinmarker Detection SoftwareTM (PDSTM) 2.0, the state of the art software for proteomic data analysis

ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics

Nautilus Biotech and HanAll Pharmaceutical announce license agreement to develop three Nautilus Biotech products in South Korea

Oxford Gene Technology and Integrated Genomics to Develop a Pichia pastoris Gene Expression Microarray

LifeCycle Pharma announces approval of its LCP-FenoChol product will not be subject to a so-called 30-month stay under the Hatch-Waxman Act

OXFORD BIOMEDICA REPORTS AVIAN TRANSGENIC MILESTONE: INTERFERON ALPHA EXPRESSED IN EGGS

Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses

Genetix acquisition expands range and scope - Applied Imaging products enhance existing cell biology portfolio

New 2007 Genetix product guide out now - Cell biology portfolio expands with new applications

Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles

BioAlliance Announces Financial Results For 2006

Organon and Acrux (ASX:ACR) announce partnership to develop contraceptive sprays

SYNTAXIN APPOINTS PHILIP BOYD AS CHIEF FINANCIAL OFFICER

Malvern Instruments secures exclusive distribution rights in the United States, South and Central America for Farfield Scientific analytical instruments

EU Regulation Urgently Needed! European Patients are Waiting for the Next Generation of Medical Treatments

Bioindustry welcomes new French legislation covering biosimilar medicines

EPPOSI calls for greater co-operation between science, industry and regulators

EU Environment Ministers vote against sound science

EuropaBio is a founding member of EPAA - A platform for Alternative Approaches to Animal Testing

Fusion Antibodies signs antibody engineering deal with ARIUS to develop new cancer antibodies

HRA PHARMA INVEST AN ADDITIONAL EUROS 2.5 M IN CELL THERAPY THROUGH ITS SUBSIDIARY CELOGOS

Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria

GSK INITIATES FIRST GLOBAL PHASE III STUDY OF TYKERB® (LAPATINIB) IN HEAD AND NECK CANCER

Cellexus Biosystems incorporates wholly owned subsidiary in the United States of America

Nautilus Biotech announces IND filing for Belerofon, its oral, long-lasting, Interferon-alpha drug

LifeCycle Pharma announces positive data from LCP-AtorFen Phase I clinical program

Kamada submits clinical program to the EMEA for phases II-III with its leading product

New ‘chromatography flow-mode’ option transforms Zetasizer Nano into in-line detector for absolute size exclusion chromatography

Malvern launches SyNIRgi - the sophisticated chemical imaging system for routine use

Hybrigenics Focuses its Research on Inhibitors of Ubiquitin-Specific Proteases in Cancer

ALPHA BIOLOGICS SET FOR GROWTH FOLLOWING ACQUISITION OF CTM BIOTECH

LifeCycle Pharma appoints Senior Vice President of Pharmaceutical Development

Launch of Biacore X100 brings protein interaction analysis within reach of every life science research lab

Magnisense and Indicia Announce Joint Testing Platform for Magnetic Marker-Based In Vitro Diagnostics

Amsterdam Molecular Therapeutics BV enters research collaboration with the University of Barcelona

STEM CELL SCIENCES AND CELOGOS SIGN A LICENSING DEAL ON AUTOGENOUS MYOBLAST TRANSPLANTATION FOR URINARY INCONTINENCE THERAPY

BioInvent Financial Statement: 1 January - 31 December 2006

Cellexus Biosystems recognised by the UK Trade & Investment for its innovative marketing.

Syngene - New multi-purpose CCD imaging system offers affordable method of analysing all DNA and protein gels

Nitec Pharma Signs German Marketing Rights for LodotraT to Merck Pharma GmbH

Unmet Need Drives Innovation in Neurodegenerative Disorder Therapy Market

The 4th Annual BioFine Europe Convention announces Conference Networking System is now live.

BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials for Anticoagulant TB-402

European arable crop profit margins 2006-2007

Geneservice acquires the DNA Sequencing facility at Biochemistry Department, University of Oxford

TTP LabTech: Screening Innovation Drives Big Orders

Principle biopharmaceutical company introduces ActivityBase XE to improve screening efficiency

Leading academic center chose IDBS to show ‘best practice’

ImVisioN Therapeutics strengthens patent position

BioAlliance Pharma Announces 2006 Consolidated Revenues

ASTRAZENECA LICENSES REGENERON'S VELOCIMMUNER TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES

Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies

Thermo Fisher Scientific Introduces New Platform for Automated Crystallization Plate Production

Thermo Fisher Scientific Introduces Automated Solution for Assay Ready Cell Culture

Thermo Fisher Scientific Introduces New Platform for Automated Crystallization Plate Production

BioAlliance Pharma Raises Free Float to 40 per cent of Capital

AM-Pharma announces the appointment of Bart Wuurman as CEO

Thermo Fisher Scientific Introduces New Class II Biological Safety Cabinets

Cobra Biomanufacturing Plc announces manufacturing agreement with Pharmexa

Oxford Gene Technology in collaboration with the Wellcome Trust Sanger Institute to develop a microarray to test for genetic defects in unborn children

Cobra appoints General Manager for Oxford Facility

Buoyant Order Book Spurs Recruitment Drive at Syrris

Tailoring the Therapy to the Cancer

FDA approves Enzon IND for Santaris Pharma's Second New Cancer Drug

Market for Wireless Technologies in Healthcare Set to Explode

World Market for Psychotherapeutic Drugs Closes in on $50 Billion in Sales

Double-Digit Growth Drives Oral Drug Delivery Market to $52 billion by 2010.

Biomarkers Emerge as High-Growth Worldwide Market for Personalized Medicine

Double-Digit Growth Expected to Drive World Cell Culture Market to $2.6 Billion

Blossoming In Vitro Diagnostics Market in India Surpasses $250 Million in 2006

World Pain Management Drugs and Devices to Top $33 Billion by 2010

ibidi releases new Chemotaxis Slide

Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study

OXFORD BIOMEDICA REPORTS AVIAN TRANSGENIC MILESTONE: INTERFERON ALPHA EXPRESSED IN EGGS

Cellexus Biosystems generates first revenues.

Dr Walter Wenninger appointed to Santaris Pharma Board

Nestlé Nutrition enters commercial discussions with Phosphagenics

OXFORD BIOMEDICA ANNOUNCES PUBLICATION OF AVIAN TRANGENIC RESULTS IN LEADING U.S. SCIENTIFIC JOURNAL

OXFORD GENE TECHNOLOGY AND AGILENT TECHNOLOGIES ENTER INTO A COLLABORATIVE AGREEMENT

DanioLabs and Senexis Announce Collaboration on Ageing Related Diseases

4-Antibody AG closes CHF 17 Million Series A financing, bringing the total Series A financing to CHF 23 Million ($ 18.5Million)

BioInvent enters collaboration with Genentech to develop and commercialize BioInvent's proprietary antibody for the treatment of cardiovascular diseases

Syngene - New GeneTools Software Is World’s First Image Analysis Package to Offer One Step E-Gel 96 Reading

Ablynx And Boehringer Ingelheim Sign $265 Million Research And Licensing Agreement To Develop New Alzheimer’s Treatments

Nautilus Biotech launches new website and corporate image

BioControl Launches International Study of Cardiofit for Heart Failure

OXFORD GENE TECHNOLOGY GRANTS EXCLUSIVE OPTION TO ITS TRIDEND TECHNOLOGY TO MASSTAG TECHNOLOGIES LTD.

OXFORD BIOMEDICA'S PHASE III TRIAL OF TROVAX IN RENAL CANCER ADOPTED BY UK CLINICAL TRIAL NETWORK

Forbion Capital Partners, formerly ABN AMRO Capital Life Sciences, spins out of ABN AMRO Capital and raises a EUR 200 M Life Sciences Fund

Lectus Therapeutics announces preclinical 'Proof-of-Concept' data

University of Crete Medical School / novosom AG Receives Funding from Sixth EU Framework Program to develop novel therapy for cancer

OXFORD GENE TECHNOLOGY AND NIMBLEGEN SYSTEMS, INC. ENTER INTO LICENSING AND SUPPLY AGREEMENTS

mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products

mtm laboratories launches proprietary CINtecR Histology and CINtecR Cytology Kits

“BioAsia 2007 Thailand” expects to attract over 15,000 visitors worldwide

OXFORD BIOMEDICA AND SIGMA-ALDRICH ISSUE JOINT LICENCE FOR LENTIVECTOR TECHNOLOGY TO GLAXOSMITHKLINE

Syrris introduce new reagent injection and product collection modules for AFRICA

OXFORD BIOMEDICA EXPANDS LICENSING AGREEMENT FOR LENTIVECTOR TECHNOLOGY WITH MAJOR PHARMACEUTICAL COMPANY

Agilent Technologies’ New Diode-Array and Multiple-Wavelength Detectors Enable Lower Detection Limits

Agilent Technologies Launches Life Science and Chemical Analysis Centers of Excellence in California, India and Europe

Agilent Technologies Announces New Technique for Rapid Analysis of Key Breast Milk Component

---

January to March 2008 Biotechnology News

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

---

Site Map - new news site

Site Map - old news site